异环磷酰胺

yì huán lín xiān àn
  • Ifosfamide
异环磷酰胺异环磷酰胺
  1. 目的与方法:本文通过Ames试验和SOS显色试验比较了环磷酰胺(CP)与异环磷酰胺(IFO)的致突变作用。

    Purpose and Methods : The mutagenicity of Cyclophosphamide ( CP ) and Ifosfamide ( IFO ) was studied using Ames test and SOS chromotest .

  2. 异环磷酰胺联合自体PHA-LAK细胞治疗晚期复发卵巢上皮癌的疗效观察

    Ifosfamide with PHA-LAK cell adoptive immunotherapy in advanced recurrent ovarian epithelial cancer

  3. 异环磷酰胺与MESNA的药理学及临床毒理学

    Pharmacology . clinical toxicology and dose schedule of ifosfamied / mesna

  4. 目的对异环磷酰胺(IFO)联合化疗治疗晚期妇科恶性肿瘤进行临床疗效和毒性评价。

    Objective To evaluate the clinical efficacy and toxicity of ifosfamide ( IFO ) combination chemotherapy in patients with advanced gynecologic malignancies .

  5. 异环磷酰胺和Vp-16治疗小细胞肺癌的疗效及癌间质血管数量对化疗敏感性的影响

    Effect of ifosfamide and Vp-16 on patients with small cell lung cancer and impact of blood vessels in mesenchyma on chemotherapeutic sensitivity

  6. 目的探讨以大剂量甲氨蝶呤、异环磷酰胺和阿霉素组成的(methotrexate,ifosfamide,doxorubicin,ADR),MMIA方案治疗骨肉瘤的可行性。

    Objective To explore the feasibility of treatment for osteosarcoma with chemotherapy regimen composed of methotrexate , ifosfamide , doxorubicin ( ADR )( MMIA ) .

  7. 目的:研究异环磷酰胺(IFO)与依托泊苷(VP16)联合治疗复发卵巢癌的疗效和毒性反应。

    Purpose : To investigate the treatment effect and toxicity of regimen containing ifosfamide ( IFO ) and etoposide ( VP16 ) on relapse ovarian carcinoma .

  8. 目的:研究异环磷酰胺(IFO)、卡铂(CBP)和平阳霉素(PYM)联合治疗复发性宫颈癌的疗效和毒性反应。

    Objectives : To investigate the treatment effect and toxicity of regimen contained ifosfamide ( IFO ) and carboplatinum ( CBP ) and pingyangmycinum ( PYM ) on relapse cervical cancer .

  9. 目的比较ITP(异环磷酰胺+吡喃阿霉素+顺铂)与NP(去甲长春花碱+顺铂)方案治疗晚期非小细胞肺癌的临床有效率和毒副作用。

    Objective To evaluate the efficacy and toxicity of ITP ( ifosfamide + perarubicin + cisplatin ) and NP ( vinorelbine + cisplatin ) regimens in the treatment of advanced non small cell lung cancer ( NSCLC ) .

  10. [目的]探讨用异环磷酰胺(IFO)、威猛(VM26)、地塞米松(DXM,VID方案)治疗复发性难治性恶性淋巴瘤疗效。

    [ Purpose ] To investigate the effect of VID regimen ( IFO , VM26 , DXM ) for the treatment of relapsed or refractory lymphoma .

  11. Ⅰ或Ⅱ期子宫癌肉瘤(混合中胚层肿瘤)全切患者术后辅以异环磷酰胺和顺铂化疗的疗效:一项GOG研究

    Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas ( mixed mesodermal tumors ) of the uterus : A Gynecologic Oncology Group study

  12. 目的:观察异环磷酰胺(IFO)联合顺铂(DDP)或足叶乙甙(VP16)治疗晚期肺癌的近期疗效和毒性反应。

    Objective : To observe the therapeutic effects and toxicity reaction of Ifosfamide ( IFO ) combined with Cisplatin ( DDP ) or Etoposide ( VP-16 ) for the treatment of advanced lung cancer .

  13. 目的:临床研究持续性静脉滴注诺维本(Navelbine,NVB)联合异环磷酰胺(Ifosfamide,IFO)治疗铂类耐药的非小细胞肺癌(NSCLC)的疗效与毒副反应。

    Objective : To evaluate the effect of continuous intravenous dripping of navelbine ( NVB ) combined with ifosfamide ( IFO ) in treatment of platinum agents resistant non-small cell lung cancer ( NSCLC ) .

  14. 目的与方法:本文研究了受孕小鼠尾静脉注射环磷酰胺(CP)和异环磷酰胺(IFO)对母鼠骨髓和胎肝微核频率及嗜多染红细胞与正成红细胞比率(PCE/NCE)的影响。

    Purpose and Methods : The frequencies of micronucleus in polychromatic erythrocytes as well as the PCE / NCE ratios in maternal bone marrow and in fetal liver induced by Cyclophsphamide ( CP ) and Ifosfamide ( IFO ) were studied in pregnancy mice .

  15. 目的探讨异环磷酰胺(IFO)联合长春瑞滨(VRL)治疗对铂类耐药的复发和/或转移的鼻咽癌的疗效和毒副反应。

    Objective To study the effectiveness and toxicity of ifosfamide ( IFO ) combined with venorelbine ( VRL ) in patients with nasopharyngeal carcinoma ( NPC ) refractory to platinum based chemotherapy .

  16. 本研究通过用四氢吡喃阿霉素(THP-ADR)替代MAID方案中的ADR和改良异环磷酰胺(IFO)用法治疗晚期软组织肉瘤,观察改良方案的疗效和不良反应。

    This study was to investigate the efficacy and toxicity of the modified MAID regimen in ASTS treatment . METHODS : In the modified regimen , adriamycin ( ADR ) was substituted with tetrahydropyranyl adriamycin ( THP-ADR ) and the application of ifosfamide ( IFO ) was modified .

  17. 异环磷酰胺在软组织肉瘤治疗中的地位

    The role of ifosfamide in the treatment of soft tissue sarcomas

  18. 异环磷酰胺联合表阿霉素治疗晚期软组织肉瘤27例疗效分析

    Epirubicin combined with ifosfamide in the treatment of advanced soft tissue sarcoma

  19. 1例静脉输注异环磷酰胺渗漏的护理

    Nursing Care of A Case With Venous Effusion After Accepted Iphosphamide Intravenous Infusion

  20. 异长春花碱加异环磷酰胺加顺铂联合化疗治疗晚期非小细胞肺癌

    Navelbine , ifosfamide and cisplatin combined chemotherapy for advanced non-small cell lung cancer

  21. 异环磷酰胺治疗恶性淋巴瘤及小细胞型肺癌的Ⅱ期临床观察

    Phase II clinical study of ifosfamide in lymphomas and small cell lung cancer

  22. 大剂量异环磷酰胺持续静滴联合阿霉素治疗进展期软组织肉瘤的临床观察

    Clinical observation of continuous-infusion with high-dose ifosfamide plus adriamycin on advanced soft tissue sarcomas

  23. 吡柔比星,异环磷酰胺和顺铂联合治疗晚期恶性肿瘤的临床观察

    Clinical observation on combined chemotherapy of THP , IFO and DOP with advanced cancer

  24. 异环磷酰胺为主要联合化疗方案治疗晚期恶性肿瘤的护理

    Nursing in the Iphosphamide Combined with Other Drugs in the Treatment of Advanced Cancer

  25. 异环磷酰胺为主的化疗方案治疗晚期恶性肿瘤疗效观察

    Clinical observation of the effectiveness of combined chemotherapy based on IFO on advanced cancers

  26. 注射用异环磷酰胺与5种输液配伍的稳定性考察

    The stability of ifosfamide in five infusions

  27. 大剂量异环磷酰胺联合方案治疗青少年晚期软组织肉瘤

    Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma in teenage patients

  28. 环磷酰胺和异环磷酰胺Balb/c小鼠肝脏毒性的基因表达谱

    Gene expression profiles showing hepatotoxicity in Balb / c mice exposed to cyclophosphamide and ifosfamide

  29. 目的:总结异环磷酰胺治疗晚期恶性肿瘤的护理经验。

    Objective : To conclude nursing experiences about treatment of late stage tumor patients by IFO .

  30. 异环磷酰胺引起心房颤动黄芪注射液致心房纤颤

    Atrial fibrilation resulting from Huangqi injection